Cytosorbents股价因关键设备监管受挫而暴跌

英为财情
Jul 03, 2025

Investing.com -- 血液净化疗法公司Cytosorbents Corporation (NASDAQ:CTSO)股价暴跌23.5%,此前该公司的DrugSorb-ATR设备同时遭到美国FDA和加拿大卫生部的监管拒绝。 该公司披露,加拿大卫生部于6月26日发布了医疗器械许可申请的拒绝通知,理由是不符合某些法规要求。Cytosorbents计划在7月25日前提交"重新考虑请求",作为规定...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10